Patient Privacy

Patients, Providers, and the Public Hesitate to Adopt Digital Pills

October 3, 2022 - On November 13, 2017, Abilify MyCite became the first digital pill approved by the United States FDA. Since this approval and the initial surge of digital pills — sometimes called smart pills — the uptake and utilization have slowed due to ethical concerns. Abilify MyCite withdrew its application to the European Medical Agency in 2020 after the agency declared that the...


More Articles

Addressing Racial Inequities in US Cancer Clinical Trials

by Alivia Kaylor

In a recent Phesi analysis of 589,295 patients participating in 6,372 United States cancer clinical trials over the last 15 years, researchers found that 42% of the African American population and 48% of the Latin American population in...